R&D activities in India have been booming: while the country only spent $2.9 billion on R&D in 2001, by 2004, this figure reached $24 billion. R&D spending is expected to reach $27.5 billion by 2010, and swell to $119 billion—2.7% of India’s estimated GDP—by 2020. There are currently 130 domestic firms and 220 multinational companies […]

While President Bush’s proposed budget for FY08 would increase the total federal R&D investment by 1.4% to $143.0 billion, federal support of basic and applied research would decline to $55.4 billion, a 2% drop from the FY07 budget. Not including NASA, the total budget increase for nondefense R&D agencies is only 0.8%, below the national […]

The fiscal 2007 federal budget was finally signed into law by President Bush on February 15. The law makes permanent most of the funding amounts in the continuing resolution passed by Congress in December 2006 that essentially froze agency and program budgets at fiscal 2006 levels. However, Congress did provide funding increases for selected programs […]

Company Announcements Under a 2006 asset purchase agreement, Advanced Chromatography Systems acquired the EZ Flash II GC accessory and the TEA analyzer organic nitrogen detection from assets of Thermo Fisher Scientific. PerkinElmer partnered with Ion Signature Technology (IST) to offer IST’s Ion Signature Quantitative Deconvolution Software to users of its Clarus 600 GC/MS. GOW-MAC Instruments […]

According to a report by the Statistics Bureau of Japan’s Ministry of Internal Affairs and Communications, total R&D expenditures for Japanese fiscal year (JFY) 2005 (April 1, 2005-March 31, 2006) were ¥17,845.2 billion ($156.5 billion), up 5.4% from JFY 2004. Of this, natural sciences R&D made up ¥16,472.1 billion ($144.5 billion). R&D was 3.53% of […]

Company Announcements NimbleGen Systems named Gregory McGuinness as vice president of International Business. He was previously director of European Business Development for Gene Logic. NimbleGen Systems obtained a license to the “Southern array patents” from Oxford Gene Technology (OGT) and will supply OGT with microarrays for use in its service business. Oxford Gene Technology granted […]

Company Announcements Proxeon appointed Mårten Winge CEO in 2006. He joined the company from Olink Bioscience. Cenix BioScience GmbH, Applied Biosystems and the Biotechnology Center of the Technische Universität Dresden established a joint facility to develop tools and methods to enable more detailed and probative analyses of the cellular functions of therapeutically relevant genes. Applied […]

Oakdale, MN 1/5/07—Dyneon, a subsidiary of 3M, has acquired 3M’s Bioanalytical Technologies business, including the Empore solid phase extraction product line, effective January 1. 3M Bioanalytical Technologies previously operated as a separate operating unit within 3M. Based in Oakdale, Minnesota, Dyneon is a suppler of fluoropolymers and has 800 employees.